本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2010/2/241 分钟阅读
Pulmonary-Allergy Drugs Advisory Committee; Amendment of Notice
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Pulmonary-Allergy Drugs Advisory Committee. This meeting was announced in the Federal Register of February 2, 2010 (75 FR 5334). The amendment is being made to reflect a change in the Name of Committee portion of the document. There are no other changes.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →